checkAd

    Orion Corporation  161  0 Kommentare Organising meeting of the Board of Directors

    ORION CORPORATION
    STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE
    20 MARCH 2024 at 17.00 EET

            
    Orion Corporation: Organising meeting of the Board of Directors

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Orion Corp B!
    Long
    29,44€
    Basispreis
    0,63
    Ask
    × 5,59
    Hebel
    Short
    39,08€
    Basispreis
    1,34
    Ask
    × 5,36
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    In its organising meeting, the Board of Directors of Orion Corporation, which was elected today by the Annual General Meeting of the Shareholders, has elected Hilpi Rautelin as Vice Chairman.

    The compositions of the Board committees were decided to be as follows:

    Personnel and Remuneration Committee:

    Veli-Matti Mattila, Chairman
    Kari Jussi Aho
    Maziar Mike Doustdar
    Hilpi Rautelin

    Audit Committee:

    Ari Lehtoranta, Chairman
    Eija Ronkainen
    Karen Lykke Sørensen
    Henrik Stenqvist  

    R&D Committee:

    Hilpi Rautelin, Chairman
    Kari Jussi Aho
    Eija Ronkainen
    Karen Lykke Sørensen

    The Company also has a Nomination Committee, the election of which was announced in a Stock Exchange Release on 28 April 2023.

    All members of the Board of Directors have been assessed to be independent of the company and its significant shareholders.

    Orion Corporation

    Liisa Hurme
    President and CEO
        Olli Huotari
    SVP, Corporate Functions
     

                                                    
    Contact person:
    Olli Huotari
    SVP, Corporate Functions

    tel. +358 50 966 3054 

    Publisher:
    Orion Corporation
    Communications
    Orionintie 1A, FI-02200 Espoo, Finland
    http://www.orion.fi/en
    http://www.twitter.com/OrionCorpIR

    Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2023 amounted to EUR 1,190 million and the company had about 3,600 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.





    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Orion Corporation Organising meeting of the Board of Directors ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE20 MARCH 2024 at 17.00 EET         Orion Corporation: Organising meeting of the Board of Directors In its organising meeting, the Board …

    Schreibe Deinen Kommentar

    Disclaimer